| Aivien Do, | |
|
420 S 5th Ave, West Reading, PA 19611-2143 | |
| (484) 628-8000 | |
| Not Available |
| Full Name | Aivien Do |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 420 S 5th Ave, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275268823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | OT021857 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aivien Do, Po Box 13579, Reading, PA 19612-3579 Ph: () - | Aivien Do, 420 S 5th Ave, West Reading, PA 19611-2143 Ph: (484) 628-8000 |
News Archive
With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in collaboration with national research institutions and private industry, are leveraging hard-won expertise to exploit a natural viral enemy of pathogenic bacteria, creating North America's first Center for Innovative Phage Applications and Therapeutics
Members of the Springfield community turned out in force to support the comprehensive treatment services provided to adults and teens by Gateway Foundation's Alcohol and Drug Rehab's Springfield Treatment Center at an April 14 Open House.
As a result of its recent acquisition announced yesterday of Optimum Mobile Imaging LLC ("OMI"), iMD is actively seeking to dramatically expand its overall Medical Diagnostics operations. Currently operating mainly in the Phoenix area, iMD will expand OMI's services throughout the state.
The National Science Foundation awarded $1,182,305 to the University of Pittsburgh Swanson School of Engineering to support research into using machine learning and Big Data to analyze electronic anesthesia records and prevent postoperative complications and death.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
› Verified 3 days ago
Dr. Mohammad Ali Khoshnoodi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 210, West Reading, PA 19611 Phone: 484-628-4656 | |
Dr. John Gurski, D.O, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-9049 | |
Dr. Jayesh P Patel, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-4879 | |
Jaswin Singh, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
Kolin Diane Good, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6th & Spruce Streets, Reading Hospital, West Reading, PA 19611 Phone: 484-628-8070 Fax: 484-628-5289 | |
Dr. Lawrence A Brzozowski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, 210, West Reading, PA 19611 Phone: 484-628-4656 Fax: 484-628-4657 | |
Wajihah Memon, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 |